Global Cell Lysis & Disruption Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Cell Lysis & Disruption Market Research Report 2024
Lysis refers to the breaking down of the membrane of a cell, often by viral, enzymic, or osmotic mechanisms that compromise its integrity. A fluid containing the contents of lysed cells is called a lysate. Cell disruption is a method or process for releasing biological molecules from inside a cell.
According to MRAResearch’s new survey, global Cell Lysis & Disruption market is projected to reach US$ 131.1 million in 2033, increasing from US$ 91 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cell Lysis & Disruption market research.
The market is growing because the higher adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cell Lysis & Disruption market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Thermo Fisher Scientific, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd
Qiagen NV
Becton Dickinson & Company (BD)
Danaher Corporation
Bio-Rad Laboratories, Inc.
Miltenyi Biotec GmbH
Claremont BioSolutions, LLC
Microfluidics International Corporation
Parr Instrument Company
BioVision, Inc.
Covaris, Inc.
Qsonica LLC
Segment by Type
Mammalian cells
Bacterial cells
Yeast/Algae/Fungi
Plant cells
Protein Isolation
Downstream Processing
Cell Organelle Isolation
Nucleic Acid Isolation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cell Lysis & Disruption report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Cell Lysis & Disruption market is projected to reach US$ 131.1 million in 2033, increasing from US$ 91 million in 2022, with the CAGR of 4.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cell Lysis & Disruption market research.
The market is growing because the higher adoption of cell lysis and disruption methods during downstream processing to manufacture bio-therapeutics and other animal-based recombinant products.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Cell Lysis & Disruption market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Thermo Fisher Scientific, Inc.
Merck KGaA
F. Hoffmann-La Roche Ltd
Qiagen NV
Becton Dickinson & Company (BD)
Danaher Corporation
Bio-Rad Laboratories, Inc.
Miltenyi Biotec GmbH
Claremont BioSolutions, LLC
Microfluidics International Corporation
Parr Instrument Company
BioVision, Inc.
Covaris, Inc.
Qsonica LLC
Segment by Type
Mammalian cells
Bacterial cells
Yeast/Algae/Fungi
Plant cells
Segment by Application
Protein Isolation
Downstream Processing
Cell Organelle Isolation
Nucleic Acid Isolation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cell Lysis & Disruption report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source